Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
G1 Therapeutics, Inc. Income Statement Banner

G1 Therapeutics, Inc. Income Statement

GTHX Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
1.043M522.000K0.0000.0000.0000.00045.285M31.476M51.301M82.511M
Cost of Revenue
5.019M12.730M67.226K89.000K175.000K356.000K0.0002.016M3.748M7.195M
Gross Profit
-3.976m-12.208m-67.226k-89.000k-175.000k-356.000k45.285M29.460M47.553M75.316M
Operating Expense
2.701M15.946M30.391M60.968M89.286M129.041M141.761M171.917M183.731M114.843M
Operating Income
-6.678m-15.424m-30.391m-60.968m-89.286m-129.041m-96.476m-142.457m-136.178m-39.527m
Other Income Expense
0.00018.000K182.372K888.000K3.998M6.594M-542.000k-346.000k3.000K2.240M
Total Other Income Expense
-64.000-4.839m100.141K847.000K3.998M6.594M-1.368m-4.970m-9.681m-5.325m
Pretax Income
-6.678m-20.263m-30.291m-60.121m-85.288m-122.447m-97.844m-147.427m-145.859m-44.852m
Tax Provision
502.364K4.857M82.231K41.000K3.998M-356.000k1.410M925.000K1.700M3.115M
Net Income
-7.181m-20.263m-30.291m-60.121m-85.288m-122.091m-99.254m-148.352m-147.559m-47.967m
Basic EPS
-5.850-0.990-1.480-3.300-2.560-3.260-2.620-3.540-3.380-0.930
Diluted EPS
-5.850-0.990-1.480-3.300-2.560-3.260-2.620-3.540-3.380-0.930
Basic Average Shares
1.227M20.429M20.429M18.198M33.317M37.499M37.878M41.943M43.626M51.733M
Diluted Average Shares
1.227M20.429M20.429M18.198M33.317M37.499M37.878M41.943M43.626M51.733M
Total Expenses
7.720M15.946M30.391M60.968M89.286M129.041M141.761M173.933M187.479M122.038M
Interest Income
912.0000.0000.0000.0000.0006.594M952.000K43.000K748.000K2.473M
Interest Expense
0.0000.0000.0000.0000.0000.0001.778M4.667M10.432M10.038M
EBITDA
-6.661m-10.525m-30.241m-60.838m-89.286m-129.041m-96.066m-142.760m-134.897m-39.014m
Depreciation & Amortization
17.314K42.000K67.226K89.000K175.000K356.000K582.000K469.000K530.000K513.000K